| Steven H Kahn, DO | |
|
2201 Chapel Ave W, Cherry Hill, NJ 08002-2048 | |
| (856) 663-7080 | |
| (856) 663-4945 |
| Full Name | Steven H Kahn |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 30 Years |
| Location | 2201 Chapel Ave W, Cherry Hill, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164461356 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | MB70844 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jefferson Home Care | Voorhees, NJ | Home health agency |
| Jefferson Stratford Hospital | Stratford, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Regional Orthopedic Professional Association | 1456325372 | 13 |
News Archive
A manmade package filled with nature's bone-building ingredients delivers the goods over time and space to heal serious bone injuries faster than products currently available, Cleveland researchers have found.
New research suggests that abnormalities in the process of blood clot formation may contribute to the pathogenesis of Alzheimer's disease. The study, published by Cell Press in the June 10 issue of the journal Neuron, advances our understanding of the link between vascular pathology and AD and proposes a new therapeutic strategy aimed at slowing cognitive decline.
Vertex Pharmaceuticals Incorporated today announced final results from its pivotal Phase 3 REALIZE study that evaluated people with genotype 1 chronic hepatitis C whose prior treatment with pegylated-interferon and ribavirin was unsuccessful either because they relapsed, had a partial response or had a null response.
While many scientists may state that stem cells are the key to longer and healthier lives, some are not waiting on the technology for that and are using it in the anti-aging industry to bring unmatched results in wrinkle removal. The ant-wrinkle and skin cream industry has been in a state of remission as far as advancements in the industry for decades.
Naurex Inc., a new clinical stage company developing innovative treatments for depression and other CNS disorders based on its novel GFPA NMDA receptor modulators, today announced that data presented at a major medical meeting showed that its lead compound GLYX-13 demonstrated robust antidepressant-like and anxiolytic-like activity with no signs of the CNS-related side effects seen with other drugs targeting the NMDA receptor.
› Verified 8 days ago
| Entity Name | Regional Orthopedic Professional Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073567095 PECOS PAC ID: 1456325372 Enrollment ID: O20040825000482 |
News Archive
A manmade package filled with nature's bone-building ingredients delivers the goods over time and space to heal serious bone injuries faster than products currently available, Cleveland researchers have found.
New research suggests that abnormalities in the process of blood clot formation may contribute to the pathogenesis of Alzheimer's disease. The study, published by Cell Press in the June 10 issue of the journal Neuron, advances our understanding of the link between vascular pathology and AD and proposes a new therapeutic strategy aimed at slowing cognitive decline.
Vertex Pharmaceuticals Incorporated today announced final results from its pivotal Phase 3 REALIZE study that evaluated people with genotype 1 chronic hepatitis C whose prior treatment with pegylated-interferon and ribavirin was unsuccessful either because they relapsed, had a partial response or had a null response.
While many scientists may state that stem cells are the key to longer and healthier lives, some are not waiting on the technology for that and are using it in the anti-aging industry to bring unmatched results in wrinkle removal. The ant-wrinkle and skin cream industry has been in a state of remission as far as advancements in the industry for decades.
Naurex Inc., a new clinical stage company developing innovative treatments for depression and other CNS disorders based on its novel GFPA NMDA receptor modulators, today announced that data presented at a major medical meeting showed that its lead compound GLYX-13 demonstrated robust antidepressant-like and anxiolytic-like activity with no signs of the CNS-related side effects seen with other drugs targeting the NMDA receptor.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Steven H Kahn, DO Po Box 8566, Cherry Hill, NJ 08002-0566 Ph: (856) 663-7080 | Steven H Kahn, DO 2201 Chapel Ave W, Cherry Hill, NJ 08002-2048 Ph: (856) 663-7080 |
News Archive
A manmade package filled with nature's bone-building ingredients delivers the goods over time and space to heal serious bone injuries faster than products currently available, Cleveland researchers have found.
New research suggests that abnormalities in the process of blood clot formation may contribute to the pathogenesis of Alzheimer's disease. The study, published by Cell Press in the June 10 issue of the journal Neuron, advances our understanding of the link between vascular pathology and AD and proposes a new therapeutic strategy aimed at slowing cognitive decline.
Vertex Pharmaceuticals Incorporated today announced final results from its pivotal Phase 3 REALIZE study that evaluated people with genotype 1 chronic hepatitis C whose prior treatment with pegylated-interferon and ribavirin was unsuccessful either because they relapsed, had a partial response or had a null response.
While many scientists may state that stem cells are the key to longer and healthier lives, some are not waiting on the technology for that and are using it in the anti-aging industry to bring unmatched results in wrinkle removal. The ant-wrinkle and skin cream industry has been in a state of remission as far as advancements in the industry for decades.
Naurex Inc., a new clinical stage company developing innovative treatments for depression and other CNS disorders based on its novel GFPA NMDA receptor modulators, today announced that data presented at a major medical meeting showed that its lead compound GLYX-13 demonstrated robust antidepressant-like and anxiolytic-like activity with no signs of the CNS-related side effects seen with other drugs targeting the NMDA receptor.
› Verified 8 days ago
Stuart G. Dubowitch, D.O. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2201 Chapel Ave W, Cherry Hill, NJ 08002 Phone: 856-663-7080 Fax: 856-663-4945 | |
Dr. Jacques Tran, DPM Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 496 Kings Hwy N Ste 210, Cherry Hill, NJ 08034 Phone: 856-667-8222 Fax: 856-667-9739 | |
Dr. David Matthew Kahan, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2090 Springdale Rd Ste C, Cherry Hill, NJ 08003 Phone: 856-751-5100 | |
Dr. Harold S Friedman, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 12 Villagio Ct, Cherry Hill, NJ 08003 Phone: 856-596-5544 | |
Dr. Robert G Ranelle, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 455 Route 70 W, Cherry Hill, NJ 08002 Phone: 856-616-2999 Fax: 856-616-1439 | |
Barry S. Gleimer, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2201 Chapel Ave W, Cherry Hill, NJ 08002 Phone: 856-663-7080 Fax: 856-663-4945 |